Business
Final number of Consideration Shares and Upda...
Malibu Life Holdings Limited has finalized the consideration shares for its acquisition of Malibu Life Reinsurance SPC, issuing an additional 21,004 Ordinary Shares to The Daniel S. Loeb Revocable Trust, bringing the total consideration shares to 1,889,809. These Balancing Action Shares are expected to be admitted to trading on the London Stock Exchange's Main Market by February 2, 2026. Following this admission, the Company will have 17,071,062 Ordinary Shares and 11,380,708 B Shares in issue, resulting in a total of 28,451,770 voting rights. Disclaimer*
About this update from Malibu Life Holdings Limited
[{"type":"text","content":"\n\n \n \n \n \n \n \n \n \n \n 28 January 2026\n \n \n \n \n \n \n \n \n \n Malibu Life Holdings Limited\n \n \n \n \n Final number of Consideration Shares\n \n \n \n \n Update on total voting rights\n \n \n \n \n \n \n \n \n \n Final number of Consideration Shares\n \n \n \n \n \n \n \n \n In connection with Malibu Life Holdings Limited's (the \"\n \n Company\n \n \") acquisition of the entire equity interests in Malibu Life Reinsurance SPC from Malibu Life Holdings LLC (the \"\n \n Seller\n \n \") (the \"\n \n Acquisition\n \n \") which completed on 12 September 2025, the Company today announces that the final number of Consideration Shares is 1,889,809. \n \n \n \n \n \n As detailed in the Company's announcement dated 12 September 2025, at Completion the Company issued 1,868,805 Ordinary Shares (being the Relevant Consideration Shares) to the Seller in consideration for the Acquisition. The number of Relevant Consideration Shares represented 95% of the Consideration Shares based on the estimated values available at the time the sale and purchase agreement between the Company and the Seller dated 21 May 2025 was entered into. That agreement contained a true-up to mechanism to allow an adjustment to take place to reflect the finalised values in respect of the Acquisition, which values have now been agreed.\n \n \n \n \n \n Therefore, in order to satisfy the total consideration for the Acquisition and pursuant to the true-up mechanism as detailed in the Company's prospectus dated 8 September 2025 (the \"\n \n Prospectus\n \n \"), the Company has allotted and will issue 21,004 Ordinary Shares (the \"\n \n Balancing Action Shares\n \n \") to The Daniel S. Loeb Revocable Trust (the \"\n \n Trust\n \n \") (who, pursuant to a deed of assignment between the Company, the Seller and the Trust dated 2 December 2025, was assigned the Seller's right to have issued and allotted to it the Consideration Shares). \n \n \n \n \n \n \n \n The Company will apply to the London Stock Exchange for the Balancing Action Shares to be admitted to trading on the Main Market for listed securities of the London Stock Exchange (the \"\n \n Main Market\n \n \")\n \n \n \n and admission to trading on the Main Market is expected to occur by 8:00 a.m. on 2 February 2026 (\"\n \n Admission\n \n \").\n \n \n \n \n  ...